Table 1.
Interactive residues of SARS‐CoV‐2 S protein.
Function | Note | Interaction Residues on S protein | Citations |
---|---|---|---|
ACE2 | Entry receptor | K417, G446, Y449, L455, F486, N487, Y489, Q493, Q498, T500, N501, G502 and Y505 | [5] |
Sialic acid binding | On glycoprotein gangliosides and possibly cell surfaces | D111, S112, K113, Q134, F135, C136, N137, F140, G142, E156, F157, R158, Y160, S161 and S162 | [16] |
Sugar binding | Sugar receptor‐interacting motif | G72, T73, N74, G75, T76, K77, and R78 | [19] |
Sugar binding | BcoV sugar‐binding domain | E154, F157, and Y160 | [19] |
HSPGs binding | Positively charged amino acids motif | R346, R355, K444, R466, and R509 | [22] |
HSPGs binding | Supporting residues | F347, S349, N354, G447, Y449, and Y451 | [22] |
HSPGs binding | GAG‐binding motif | Y453, R454, L455, F456, R457, K458 and S459 | [23] |
HSPGs binding | XBBXBX GAG‐binding motif | S1/S2 site P681, R682, R683, A684, R685, and S686 | [23] |
HSPGs binding | GAG‐binding motif on S2 fusion | S810, K811, P812, S813, K814, R815, and S816 | [23] |
CLRs binding | CD209L/L‐SIGN CD209/DSIGN binding and detour entry receptor | Over the receptor binding domain and hypothetically binding sites are N344, N371, T376, F377, K378, C379, Y380, G381, N448, Y449, N450, Y451 | [27, 28] |
NRP1 binding | C‐terminal RXXROH motif, binding and detour entry receptor | S1/S2 site, T676, Q677, T678, N679, S680, P681, R682, R683, A684, and R685 | [24] |
Protease cleavage | Furin, TMPRSS2, trypsin, matriptase cathepsin B‐L, PC1 | P681, R682, R683, A684, R685, S686, and V687 | [36] |